Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP Vaccine

Clinical trial NCT02038907 · COMPLETED

Trial details

NCT number: NCT02038907
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Healthy Volunteers Norovirus, Prevention

Start date: 2014-03-28
Primary completion: 2015-06-19
Enrollment: 420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.